About Careers MedBlog Contact us
Medindia LOGIN REGISTER
Advertisement

HIV-infected Injection Drug Users may Be Benefited by Using HAART

by Rajashri on August 6, 2008 at 2:51 PM
Font : A-A+

 HIV-infected Injection Drug Users may Be Benefited by Using HAART

Highly active antiretroviral therapy (HAART) can be as beneficial for HIV-infected injection drug users (IDUs) as for non-users, according to new research from the University of British Columbia and St. Paul's Hospital, Vancouver, Canada.

The new finding counters the belief that HIV infected IDUs were less likely to benefit from HAART.

Advertisement

During the study, the researchers found little difference in the survival rate between IDUs and non-IDUs after 4-5 years of receiving the treatment.

Since the mid-1990s, significant reductions have been observed in illness and death related to the human immunodeficiency virus (HIV) among patients receiving HAART.
Advertisement

"However, a large number of prior reports have demonstrated that because of issues of social instability related to illicit drug addiction, HIV-infected IDUs may not be deriving the full benefits of HAART," wrote the authors.

For the study, the research team led by Dr. Julio S. G. Montaner of the University of British Columbia and St. Paul's Hospital, Vancouver compared the rate of death between 3,116 patients with and without a history of injection drug use initiating HAART in a HIV/AIDS treatment program in British Columbia, Canada.

Of the 3,116 patients, 915 were IDUs (29.4 percent).

Treatment with HAART was initiated between August 1996 and June 2006. The median (midpoint) duration of follow-up was 5.3 years for IDUs and 4.3 years for non-IDUs. Patients were followed up until June 30, 2007.

During the study period, 622 individuals died that included 232 IDUs and 390 non-IDUs.

Through seven years after the initiation of HAART, the researchers found that the cumulative all-cause mortality rate was not statistically different between the 915 and 2,201 non-IDUs.

Further analysis also showed similar rates of death for both groups, after adjustment for age, sex, baseline AIDS diagnosis, baseline CD4 cell count, adherence and physician experience.

"Although our findings cannot be generalized outside of [this] cohort, as efforts to improve use of HAART among IDUs expand, the fact that survival patterns were not significantly different between IDUs and non-IDUs should help to challenge the increasingly prevalent belief that IDUs may be markedly less likely to benefit from HAART," said the authors.

"Based on these results, we conclude that HAART regimens may have effectiveness at a populational level that is not significantly different regarding the survival of individuals with and without a history of injection drug use," they added.

The study appears in the journal JAMA.

Source: ANI
RAS/L
Advertisement

Advertisement
Advertisement

Recommended Reading

Latest AIDS/HIV News

 HIV Antibody Response Raised in Patients With Tuberculosis Disease
A new study has found that the co-localization of tuberculosis disease and HIV in lymphatic tissues leads to the emergence of potent HIV antibodies.
Exploring the Consistent Outcomes of an Antiviral Drug
Specific antiviral drug that is widely used to treat smallpox patients since last summer's outbreak is found to produce similar outcomes regardless of the patient's HIV status.
Why Is STI and HIV Screening Decreased While Positive Test Results Increase?
In susceptible communities because of poverty, and racism, the effects of inadequate STI and HIV screening may be more profound.
Who Is Responsible for the Blunting of AIDS Epidemic?
In India, annual HIV infections and AIDS-related deaths continue to drop. Between 2010 and 2021, new HIV infections dropped by 46%.
Are Countries Missing on HIV Self-Testing?
Globally, all countries have promised to end AIDS by 2030, for which it is essential to safeguard individuals living with HIV to complete HIV care services.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close
×

HIV-infected Injection Drug Users may Be Benefited by Using HAART Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests